- Home
- GLPG vs GBX Comparison
GLPG vs GBX Comparison
Compare GLPG & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- GBX
- Stock Information
- Founded
- GLPG 1999
- GBX 1974
- Country
- GLPG Belgium
- GBX United States
- Employees
- GLPG N/A
- GBX N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- GBX Railroads
- Sector
- GLPG Health Care
- GBX Industrials
- Exchange
- GLPG Nasdaq
- GBX Nasdaq
- Market Cap
- GLPG 1.8B
- GBX 1.8B
- IPO Year
- GLPG 2005
- GBX N/A
- Fundamental
- Price
- GLPG $26.49
- GBX $42.87
- Analyst Decision
- GLPG Sell
- GBX Hold
- Analyst Count
- GLPG 4
- GBX 2
- Target Price
- GLPG $25.33
- GBX $57.00
- AVG Volume (30 Days)
- GLPG 389.2K
- GBX 846.6K
- Earning Date
- GLPG 04-23-2025
- GBX 04-07-2025
- Dividend Yield
- GLPG N/A
- GBX 3.00%
- EPS Growth
- GLPG N/A
- GBX 85.75
- EPS
- GLPG N/A
- GBX 6.26
- Revenue
- GLPG $311,493,731.00
- GBX $3,511,200,000.00
- Revenue This Year
- GLPG $0.08
- GBX N/A
- Revenue Next Year
- GLPG $0.23
- GBX $2.71
- P/E Ratio
- GLPG N/A
- GBX $6.82
- Revenue Growth
- GLPG 18.32
- GBX N/A
- 52 Week Low
- GLPG $22.36
- GBX $37.77
- 52 Week High
- GLPG $31.23
- GBX $71.06
- Technical
- Relative Strength Index (RSI)
- GLPG 65.43
- GBX 38.14
- Support Level
- GLPG $24.31
- GBX $40.90
- Resistance Level
- GLPG $24.91
- GBX $44.80
- Average True Range (ATR)
- GLPG 0.83
- GBX 2.55
- MACD
- GLPG 0.27
- GBX 0.33
- Stochastic Oscillator
- GLPG 95.59
- GBX 55.74
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of revenue from the United States.